BioSpace News Archive

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that three abstracts highlighting data from its hepatitis B clinical program and one health outcomes research abstract have been accepted for oral and poster presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®.

AbbVie (NYSE: ABBV) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of risankizumab (SKYRIZI®, 150 mg, subcutaneous injection at week 0, week 4 and every 12 weeks thereafter) alone or in combination with methotrexate (MTX).

Breg, Inc., a leading orthopedic bracing and billing services company, announced the appointment of Jonathon Singer to chief financial officer.

Helix BioPharma Corp. announced that it anticipates the filing of its annual financial statements, management’s discussion and analysis, annual information form and related officer certifications for the financial year ended July 31, 2021 will be delayed beyond the required filing deadline.

Boehringer Ingelheim announced the U.S. Food and Drug Administration approved the supplemental Biologics License Application for Cyltezo® as the first Interchangeable biosimilar with Humira®.